Olivieri C, Wang Y, Walker C, Veliparambil Subrahmanian M, Ha K, Bernlohr D
Elife. 2024; 12.
PMID: 38913408
PMC: 11196109.
DOI: 10.7554/eLife.91506.
Zhu Y, Ding W, Chen Y, Shan Y, Liu C, Fan X
Nat Chem. 2024; 16(4):533-542.
PMID: 38418535
DOI: 10.1038/s41557-024-01463-7.
Lee J, Gebauer E, Seeliger M, Bahar I
Curr Opin Struct Biol. 2024; 84:102770.
PMID: 38211377
PMC: 11044982.
DOI: 10.1016/j.sbi.2023.102770.
Balasundaram A, Doss G
ACS Omega. 2023; 8(46):43856-43872.
PMID: 38027370
PMC: 10666221.
DOI: 10.1021/acsomega.3c05785.
Liang Y, Qie Y, Yang J, Wu R, Cui S, Zhao Y
Nat Commun. 2023; 14(1):4898.
PMID: 37580346
PMC: 10425332.
DOI: 10.1038/s41467-023-40589-z.
The structural basis of the multi-step allosteric activation of Aurora B kinase.
Segura-Pena D, Hovet O, Gogoi H, Dawicki-McKenna J, Hansen Woien S, Carrer M
Elife. 2023; 12.
PMID: 37227118
PMC: 10259393.
DOI: 10.7554/eLife.85328.
Conformational changes in protein kinase A along its activation cycle are rooted in the folding energetics of cyclic-nucleotide binding domains.
Chau A, Bracken K, Bai L, Pham D, Good L, Maillard R
J Biol Chem. 2023; 299(6):104790.
PMID: 37150322
PMC: 10279917.
DOI: 10.1016/j.jbc.2023.104790.
Allosteric regulation and inhibition of protein kinases.
Mingione V, Paung Y, Outhwaite I, Seeliger M
Biochem Soc Trans. 2023; 51(1):373-385.
PMID: 36794774
PMC: 10089111.
DOI: 10.1042/BST20220940.
Probing conformational landscapes and mechanisms of allosteric communication in the functional states of the ABL kinase domain using multiscale simulations and network-based mutational profiling of allosteric residue potentials.
Krishnan K, Tian H, Tao P, Verkhivker G
J Chem Phys. 2022; 157(24):245101.
PMID: 36586979
PMC: 11184971.
DOI: 10.1063/5.0133826.
ATP-competitive inhibitors modulate the substrate binding cooperativity of a kinase by altering its conformational entropy.
Olivieri C, Li G, Wang Y, V S M, Walker C, Kim J
Sci Adv. 2022; 8(30):eabo0696.
PMID: 35905186
PMC: 9337769.
DOI: 10.1126/sciadv.abo0696.
Evaluation of residue variability in a conformation-specific context and during evolutionary sequence reconstruction narrows drug resistance selection in Abl1 tyrosine kinase.
Otsuka F, Bjelic S
Protein Sci. 2022; 31(7):e4354.
PMID: 35762721
PMC: 9202545.
DOI: 10.1002/pro.4354.
Validation of an Allosteric Binding Site of Src Kinase Identified by Unbiased Ligand Binding Simulations.
Mingione V, Foda Z, Paung Y, Philipose H, Rangwala A, Shan Y
J Mol Biol. 2022; 434(17):167628.
PMID: 35595169
PMC: 9713948.
DOI: 10.1016/j.jmb.2022.167628.
Resistance to kinase inhibition through shortened target engagement.
Rangwala A, Berger B, Robers M, Knapp S, Seeliger M
Mol Cell Oncol. 2022; 9(1):2029999.
PMID: 35252553
PMC: 8890393.
DOI: 10.1080/23723556.2022.2029999.
Programmable allosteric DNA regulations for molecular networks and nanomachines.
Zhang C, Ma X, Zheng X, Ke Y, Chen K, Liu D
Sci Adv. 2022; 8(5):eabl4589.
PMID: 35108052
PMC: 8809682.
DOI: 10.1126/sciadv.abl4589.
Molecular mechanism of glycolytic flux control intrinsic to human phosphoglycerate kinase.
Yagi H, Kasai T, Rioual E, Ikeya T, Kigawa T
Proc Natl Acad Sci U S A. 2021; 118(50).
PMID: 34893542
PMC: 8685715.
DOI: 10.1073/pnas.2112986118.
Multiscale computational study of ligand binding pathways: Case of p38 MAP kinase and its inhibitors.
Huang Y
Biophys J. 2021; 120(18):3881-3892.
PMID: 34453922
PMC: 8511166.
DOI: 10.1016/j.bpj.2021.08.026.
The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.
Parkins A, Skeens E, McCallum C, Lisi G, Pantouris G
Biophys J. 2021; 120(18):3893-3900.
PMID: 34437846
PMC: 8511117.
DOI: 10.1016/j.bpj.2021.08.025.
Is Disrupted Nucleotide-Substrate Cooperativity a Common Trait for Cushing's Syndrome Driving Mutations of Protein Kinase A?.
Walker C, Wang Y, Olivieri C, V S M, Gao J, Bernlohr D
J Mol Biol. 2021; 433(18):167123.
PMID: 34224748
PMC: 8409435.
DOI: 10.1016/j.jmb.2021.167123.
Reduced efficacy of a Src kinase inhibitor in crowded protein solution.
Kasahara K, Re S, Nawrocki G, Oshima H, Mishima-Tsumagari C, Miyata-Yabuki Y
Nat Commun. 2021; 12(1):4099.
PMID: 34215742
PMC: 8253829.
DOI: 10.1038/s41467-021-24349-5.
Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative.
Chakraborty M, Bhattacharyya S, Roy S, Bhattacharya I, Das R, Mukherjee A
J Biol Chem. 2021; 296:100449.
PMID: 33617879
PMC: 7946438.
DOI: 10.1016/j.jbc.2021.100449.